SI-BONE Operating Income

The latest operating income for SIBN is $-18M as of June 2026. That compares with $-28M in the prior-year period — up 35.7% year over year. Investors often review this figure alongside SI-BONE's historical trend and sector peers before judging valuation or financial health.

Over the past year, SIBN's operating income moved from $-28M to $-18M — a 35.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in SI-BONE's operating scale or balance-sheet position.

A operating income figure of $-18M for SIBN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SIBN's operating income ($-18M), review year-over-year change from $-28M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack SI-BONE's operating income against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.